Sign in
Enter your work email to continue. Your organization is detected automatically.
⚠
Your Organization
Your organization uses single sign-on. You'll be redirected to your identity provider.
Organization
SSO via Azure AD
🔐 Sign in with your Azure AD credentials — no separate Onvera password needed.
Enter your password
Organization
you@org.com
Change
⚠
Forgot password?
👁
Select a location
You have access to multiple locations. Select which one you are working on today.
Two-factor authentication
Enter the 6-digit code from your authenticator app.
⚠
30
Code refreshes in 30s  ·  Send SMS instead
Reset your password
Enter your work email and we'll send a reset link valid for 15 minutes.
⚠
✓
Check your email
We sent a reset link to .
It expires in 15 minutes and can only be used once.
✓ Didn't receive it? Try again
Create your password
Must be at least 12 characters. Onvera enforces NIST 800-63B.
👁
👁
✓
Signed in
Redirecting to your dashboard…
Loading…
Forgot password? · Contact Support · Privacy
Email us at support@onverahealth.com  or fill out the support form
🏢 Acting on behalf of: — · All actions logged under your firm credentials
📍
Loading…
—
▾
Your authorized locations
Switching locations does not require re-login. Your session remains active.
Good morning 👋
+ New Patient
⤓
Ingestion
847 docs · 3 sources
›
◈
Casefinding
124 suspects found
›
⚡
Abstraction
Onvera AI · 112 fields
›
◇
Workbench
12 pending review
›
✓
Validation
450+ edits · 2 warnings
›
◻
Submissions
100 submitted · 12 pending
Today
This week
This month
YTD
🖨 Print
⬇ Export PDF
← Back
Eleanor T. Bishop
● Active case
Stage IIA
MRN-2024-09102 · DOB: 1958-06-14 · F · Dx: Oct 22, 2024 · Breast C50.4
Abstract →
Review
Demographics
Diagnosis
Abstraction (NAACCR)
Documents 3
Submission History
Audit Trail
Personal Information
Edit
First Name
Eleanor
Last Name
Bishop
Date of Birth
Jun 14, 1958 (66 yrs)
Sex at Birth
Female
Race
White
Ethnicity
Non-Hispanic
Address
2847 Westbrook Lane, Richmond, VA 23228
MRN
MRN-2024-09102
SSN (last 4)
••••7842
Registry Status
Reportability
AI confidence: 98%
✓ Reportable
Case status: Abstracted
Pipeline stage: Workbench
Received: Oct 22, 2024
Dx date: Oct 18, 2024
Days in system: 27
Timeliness: On track
Assigned to: Registrar
Registry
Registry
Incidence report · NAACCR v24 · 30th of month
AI Pipeline
OCR
›
De-ID
›
Classify
›
Casefinding
›
Abstracting
›
Validation
›
Workbench
● LIVE
Review in Workbench →
Processing
3
Completed today
14
Avg confidence
94%
Avg time/case
8.2s
Auto-routed
11
Flagged
2
Abstraction Queue
● Processing now
MRN-2024-08841
BREAST
Martha L. Henderson
Abstracting…
34 of 50 fields extracted · Breast model
MRN-2024-08839
COLON
Robert J. Tanner
De-identifying…
OCR complete · Colon model queued
MRN-2024-08836
LUNG
Patricia A. Nguyen
OCR…
3 documents · Lung model ready
✓ Completed today (14)
MRN-2024-08834
✓ T1 Auto
David M. Okonkwo
Prostate · 98% · 7.8s · Sent to workbench
MRN-2024-08831
✓ T1 Auto
Susan K. Patel
Ovary · 97% · 9.1s · Sent to workbench
MRN-2024-08820
⚠ T3 Review
Thomas R. Garcia
Colon · 88% · 11.3s · 1 field flagged
View all 14 completed →
PathReport_Henderson_20241003.pdf
Martha L. Henderson · MRN-2024-08841 · Source: Manual Upload · Received Oct 3, 2024
Pathology
IHC Report
CT Report
EMR Note
Breast model v2.4
PATHOLOGY REPORT — ORGANIZATION
Patient: Martha L. Henderson    MRN: 2024-08841
DOB: 1957-03-14    Accession: ACC-2024-10-003
Received: 2024-10-03    Reported: 2024-10-05

CLINICAL HISTORY:
67-year-old female with right breast mass on screening mammogram.
Biopsy performed for 28mm spiculated right upper outer quadrant mass.

GROSS DESCRIPTION:
Core needle biopsy, right breast. 5 cores submitted, each measuring 1.5-1.8 cm.

MICROSCOPIC DESCRIPTION:
Sections show cores of breast tissue with an invasive ductal carcinoma, grade 2
(modified Bloom-Richardson: tubules 2, nuclear grade 2, mitoses 1; total score 5).
Tumor measures 2.8 cm in greatest dimension. Lymphovascular invasion not identified.

MARGINS: Free of tumor (closest margin >2mm — see note re: excisional specimen)

IMMUNOHISTOCHEMISTRY:
ER: Positive, 90% of cells, strong intensity (Allred score 8/8)
PR: Positive, 70% of cells, moderate intensity (Allred score 7/8)
HER2: Negative (score 1+) — FISH not indicated
Ki-67: 18% (intermediate)

ICD-O CODES:
Site: C50.4 — Upper-outer quadrant, right breast
Histology: 8500/3 — Infiltrating duct carcinoma, NOS
Grade: 2 — Moderately differentiated

NOTE: Margin status requires correlation with excisional specimen.
Registrar flag raised for margin field — recommend review.

Signed: Dr. M. Osei, MD, Pathology · Organization · 2024-10-05
IHC REPORT — VOA PATHOLOGY
Patient: Martha L. Henderson    Accession: VOA-IHC-2024-08841
Specimen: Right breast core biopsy

IMMUNOHISTOCHEMICAL RESULTS:
ER (SP1 clone): POSITIVE — 90% nuclear staining, 3+ intensity (Allred 8/8)
PR (SP2 clone): POSITIVE — 70% nuclear staining, 2+ intensity (Allred 7/8)
HER2 (4B5 clone): NEGATIVE — Score 1+ (weak, incomplete membrane staining)
Ki-67 (MIB-1): 18% (intermediate proliferative index)

✓ AI cross-reference: IHC results consistent with pathology report. No conflicts.
CT CHEST/ABDOMEN/PELVIS — EPIC RADIANT
Patient: Martha L. Henderson    Date: 2024-10-12

FINDINGS:
CHEST: No pulmonary nodules or masses. No pleural effusion. No mediastinal lymphadenopathy.
BREAST: Spiculated mass right upper outer quadrant measuring 28 mm on axial imaging.
ABDOMEN: No hepatic lesions. No abdominal lymphadenopathy.
PELVIS: No pelvic masses. No pelvic lymphadenopathy.

⚠ AI Note: Tumor size discrepancy — path report (2.8cm) vs imaging (28mm). Values equivalent; unit discrepancy flagged for registrar confirmation.
ONCOLOGY NOTE — EPIC EHR
Encounter: 2024-10-15    Provider: Dr. Aisha Osei, MD

ASSESSMENT:
Martha Henderson, 67F, newly diagnosed with
right breast invasive ductal carcinoma, Stage IIA (cT2N0M0).

PLAN:
Neoadjuvant AC-T regimen initiated (Adriamycin 60mg/m², Cyclophosphamide 600mg/m²)
followed by Taxol. Aromatase inhibitor (Anastrozole) planned following chemotherapy
given ER+ status.
Live Extraction Stream
Fields extracted in real-time as AI reads
34/50
Overall confidence
94%
⚠ Multi-document conflict
Tumor size: Path report (2.8cm) vs CT (28mm). Values equivalent — unit discrepancy flagged for registrar confirmation.
AI resolution: Coded as 028mm · Confidence reduced to 82%
Primary site
99%
C50.4
→ "right upper outer quadrant" · PathReport p.1
Histology
97%
8500/3
→ "invasive ductal carcinoma" · PathReport p.2
Grade
95%
2 — Moderate
→ Bloom-Richardson score 5/9 · PathReport p.2
Laterality
99%
Right (2)
→ Confirmed in 3 source docs · PathReport + CT + EMR
Tumor size
82% ⚠
028 mm
→ Unit conflict: path (2.8cm) vs CT (28mm) · Flagged
ER status
99%
Positive · 90%
→ Confirmed: PathReport + IHC Report · 2 sources
PR status
98%
Positive · 70%
→ PathReport + IHC Report · Consistent
HER2 overall
98%
Negative (1+)
→ IHC: score 1+, FISH not indicated · IHC Report
AJCC Stage
94%
IIA (calculated)
→ T2 N0 M0 per AJCC 8th ed. · Auto-calculated
Chemotherapy
95%
01 — AC-T regimen
→ Epic treatment plan · Adriamycin + Cyclophosphamide
Hormone therapy
97%
01 — Anastrozole planned
→ EMR note: aromatase inhibitor post-chemo · ER+
Margins
74% ⚠
Conditional — needs review
→ "Requires correlation with excisional specimen"
Ki-67 proliferative index
extracting…
⏳ Pending: Date of diagnosis · Sequence # · Class of case · Marital status · Census tract · …16 more
AI Model
ModelBreast cancer v2.4
NAACCR versionv24
AJCC edition8th (auto)
Documents read4 (path, IHC, CT, EMR)
RAG knowledge baseNCCN v2024.1
New Patient Registration
Registry intake — links patient to EMR and opens AI abstraction pipeline
Save draft
Register & start AI pipeline →
Patient Demographics
Pulled from EMR on MRN match · verify before registering
Last name *
First name *
Middle name / initial
Date of birth *
Sex at birth *
SSN (full — required for VCR)
Address at diagnosis *
Address at diagnosis determines VCR/NCCR jurisdiction and census tract assignment
Race (NAACCR item 160)
Ethnicity (NAACCR item 190)
Marital status at dx
MRN / Patient ID *
Look up in EMR
Case Information
Registry-specific fields — determines reportability and routing
Class of case (NAACCR item 610) *
Analytic case — full abstraction required
Preliminary cancer type
Diagnosis date (if known)
NAACCR item 390 — date of first definitive diagnosis
Documents expected / received
Suspense file?
Use for cases where reportability cannot yet be determined
Attending physician (for registry)
Registrar notes
Registry & Research Notifications
1 pending
–
Cancer Registry Reporting Notification
Mandatory notice — Virginia Code § 32.1-70 requires reporting this cancer case to the VCR. Patient notification is required. This is not consent — reporting is mandatory regardless.
Not sent
Send notification
–
Research Authorization (optional)
Patient authorization for de-identified data use in oncology research. Not required for registry reporting. Can be collected separately.
Not requested
Request
Registration Status
Demographics
⏳ In progress
MRN linked to EMR
Pending lookup
Class of case assigned
✓ Class 10
Registry notification
⏳ Pending
AI pipeline
Awaiting registration
VCR — Virginia reporting
Cases at Main Campus report to the Registry via the submission portal. Submission deadline: 30th of each month. NAACCR v24.
AI Pipeline (on register)
1
Casefinding & reportability
ICD-10 trigger code scan · 98.4% AI accuracy
2
Document ingestion opens
Epic + Ontada + Quest auto-pull begins
3
AI abstraction (on path receipt)
NAACCR v24 · 450+ edits · avg 8.2s
4
Tier routing → CTR Workbench
T1 auto · T2 quick · T3-T5 CTR review
5
NAACCR validation → VCR submission
eMaRC Plus · monthly by 5th
Module
Document Ingestion
Documents today
41+8
Processing now
3in queue
Success rate
99.1%
Avg AI time
3.2s
Failed today
0
Total ingested
847
AI Pipeline
OCR
De-ID
Class.
Casefinding
Abstract
🔍
📅All dates▾
Showing 7 of 847
⚡ Sources
⤒ Upload
Document / Patient ↕
Source ↕
Type ↕
Received ↕
AI Status ↕
Conf. ↕
Action
PathReport_Henderson_20241003
Martha L. Henderson · MRN-2024-08841 · 847 KB
Manual Upload
Pathology
Oct 3
Abstracted
94%
View
IHC_Report_Henderson_20241008
Martha L. Henderson · MRN-2024-08841 · 234 KB
Ontada G2
Lab / IHC
Oct 8
Abstracted
98%
View
CT_ChestAbdPelvis_Henderson
Martha L. Henderson · MRN-2024-08841 · 1.2 MB
Epic EHR
Imaging
Oct 12
Abstracted
91%
View
PathReport_Tanner_20241015
Robert J. Tanner · MRN-2024-08839 · 612 KB
Ontada G2
Pathology
Oct 15
Abstracted
98%
View
LabResults_Nguyen_CBC_20241018
Patricia A. Nguyen · MRN-2024-08836 · 88 KB
Quest Labs
Lab
Oct 18
Abstracted
96%
View
OpReport_Okonkwo_20241021
David M. Okonkwo · MRN-2024-08834 · 156 KB
Epic EHR
EMR Note
Oct 21
Casefinding…
—
View
Manual_PathReport_Garcia.pdf
Thomas R. Garcia · MRN-2024-08820 · 2.1 MB
Manual Upload
Manual
Oct 22
OCR…
—
View
Queue today
24
Auto-approval
76%
Avg AI conf.
94%
Signed off
11
Overdue
1
Case tiers:
T19 auto
T25 quick
T36 review
T43 manual
T51 complex
▦ Worklist
▤ Case view
⚡ Batch Signoff 9
🔍
All
Name
MRN
Site
All
⚡ Ready to approve
⚠ Needs review
⏱ Due ≤14d
—
Patient Site / Histology Stage Tier AI confidence Status Due (VCR) ▲ Flags
0 cases selected ·
Clear
⚡ Approve & submit selected
Submission Pathway
10 VA locations
Onvera → eMaRC Plus → Virginia Web Plus → VCR/VDH ✓
2 NC locations
Onvera → NCDR Web Plus → NCCR ✓ + dual-report to VCR where applicable
VCR deadline
9 days
? VCR Help
⚡ Submit All (VCR + NCCR)
Ready to submit
12
Submitted YTD
847
Accepted
843
Rejected
4
Acceptance rate
99.5%
Ready 12
Submitted 847
Rejected 4
✓ Validated · ready to submit
MRN-2024-08841
✓ Valid
Martha L. Henderson
Breast C50.4 · Stage IIA · 94%
MRN-2024-08839
✓ Valid
Robert J. Tanner
Colon C18.2 · Stage III · 98%
MRN-2024-08831
✓ Valid
Susan K. Patel
Ovary C56 · Stage IIIC · 97%
…and 9 more ready
Martha L. Henderson
MRN-2024-08841 · Breast C50.4 · Stage IIA
✓ Ready to submit
Submit to VCR →
Submission Record
Format
NAACCR v24 flat file
Registry
Registry
Report type
Incidence · NAACCR A
Batch
November 2024
Deadline
Nov 5, 2024 (9 days)
Validation status
✓ All edits passed
NAACCR Fields Preview
⬇ Download flat file
Record type A · Patient: Henderson, Martha L. · MRN-2024-08841
Item 10 (Record Type): A
Item 400 (Primary Site): C504
Item 522 (Histology): 8500
Item 523 (Behavior): 3
Item 440 (Grade): 2
Item 410 (Laterality): 2
Item 2800 (Tumor Size): 028 ⚠ confirm
Item 490 (Dx Date): 20241003
…112 fields total
REGISTRY DEADLINE
12d
30th of each month
Cases Today
24
+6 vs yesterday
Pending Review
12
needs attention
AI Accuracy
94.2%
+1.4% this month
Follow-up Overdue
3
past 180-day threshold
Rejected
4
needs resubmission
Actions Needed
4 items
View all →
⚠️
12 cases need registrar review
Oldest: 2 days · 1 overdue
12
✗
4 submissions rejected
NAACCR edit errors — resubmit
4
⏱
3 patients follow-up overdue
Past 180-day threshold
3
📤
2 cases ready to submit
Approved + validated
Ready
Cases by Site · YTD
Full analytics →
Breast
72
Colon/Rectal
48
Lung
38
Prostate
32
Other
18
Total YTD: 208 cases USA State Registry
Recent Activity
Full audit log →
✓
Walsh, C. submitted — accepted
2 hours ago · Alex Morgan
✓
Tanner, R. abstract approved — ready to submit
3 hours ago · Alex Morgan
✗
Okonkwo, D. registry rejected — Edit 1270 date conflict
4 hours ago · USA State Registry
⏱
Novak, J. follow-up now 12 days overdue
5 hours ago · System
⤓
3 path reports uploaded — queued for AI
5 hours ago · Manual upload
Screened today
41
Reportable
24
Non-reportable
11
Suspense file
6
AI accuracy
98.4%
CoC 4.4 rate
99.1%
Pending 8
Confirmed 24
Suspense 6
🔍
MRN-2024-09102
98% REPORTABLE
Eleanor T. Bishop
ICD-10: C50.411 · Breast, UOQ, right
98%
3 trigger codes · Path confirmed · Registry reportable
MRN-2024-09098
84% REVIEW
Marcus L. Freeman
ICD-10: K63.5 · Polyp of colon
84%
⚠ Polyp vs adenocarcinoma — path needed
MRN-2024-09091
96% REPORTABLE
Diana R. Wolfe
ICD-10: C34.11 · Lung, upper lobe, right
96%
NSCLC · 2 trigger codes · Path report received
MRN-2024-09087
62% UNCERTAIN
James A. Nguyen
ICD-10: D12.6 · Adenoma of colon
62%
⚠ Low-grade dysplasia — may not be reportable
MRN-2024-09081
99% REPORTABLE
Priya S. Chandran
ICD-10: C56.1 · Ovary, right
99%
High-grade serous · BRCA1+ · Stage IIIC
Eleanor T. Bishop
MRN-2024-09102 · DOB: 1958-06-14 · F · Received Oct 22, 2024
AI: 98% Reportable
→ Suspense
✗ Non-reportable
✓ Confirm Reportable
✓ Reportable — Registry
98%
Onvera AI has determined this case is reportable to the Registry with 98% confidence. Pathology confirms invasive malignancy (ICD-O-3 8500/3) at a reportable site (C50.4). All three primary reportability criteria are met.
Malignancy confirmed
99%
Site reportable
99%
First diagnosis here
96%
🎯 Trigger Codes Fired
C50.411
Malignant neoplasm of upper-outer quadrant of right female breast
ICD-10-CM · Primary diagnosis code · PathReport + EMR
✓ Confirmed
8500/3
Infiltrating duct carcinoma, NOS — Malignant behavior
ICD-O-3 Histology · Behavior /3 = reportable · PathReport
✓ Confirmed
C50.4
Upper-outer quadrant of breast — Reportable site
ICD-O-3 Site · In Registry reportable site list · NAACCR v24
✓ Confirmed
📋 Reportability Rules
REG Rule
Registry requires reporting of all malignant neoplasms (ICD-O-3 behavior /3) diagnosed in Virginia residents. Registry reporting statute.
SEER Rule
Invasive breast carcinoma (8500/3, C50.x) is reportable per SEER Program Coding Manual 2023. First-time diagnosis confirmed — not a recurrence.
CoC 4.4
Case abstracted within 6 months of diagnosis per CoC Standard 4.4 (timeliness). Diagnosis date: Oct 3, 2024. Deadline: Apr 3, 2025. 19 days elapsed.
CoC Standard 4.4 — Completeness
9/10
✓Demographics
✓Primary site
✓Histology (ICD-O-3)
✓Date of diagnosis
✓Stage group
✓First course treatment
✓Sequence number
✓Vital status
✓Class of case
⚠Margins — pending excision
🔍 Prior Cancer History Check
VCR registry query✓ No prior entries found
Epic EHR history✓ No prior malignancy
SSDI / death check✓ Patient alive
Sequence assignment01 — First primary
Source Evidence
Documents that triggered casefinding
Pathology Report
PRIMARY
"…invasive ductal carcinoma, grade 2, arising in right upper outer quadrant…"
PathReport_Bishop_20241018 · Page 2 · Trigger: 8500/3, C50.4
EMR Diagnosis Code
CONFIRMS
Encounter diagnosis: C50.411
"Malignant neoplasm of upper-outer quadrant of right female breast"
Epic EHR · Encounter 2024-10-18 · Trigger: C50.411
Decision audit trail
AI determination: Reportable (98%)
Pending registrar confirmation
Registrar · CTR · Today
Edits checked
450+
Passed
448
Needs review
2
Auto-fixed
14
VCR errors
0
Cases with edits
MRN-2024-08841
2 edits
Martha L. Henderson
Breast C50.4 · Stage IIA · Edit 60, Edit 1270
MRN-2024-08834
0 edits
David M. Okonkwo
✓ All 450+ edits passed
MRN-2024-08839
0 edits
Robert J. Tanner
✓ All edits passed · Auto-approved
Martha L. Henderson
MRN-2024-08841 · Breast C50.4 · Stage IIA
Open in Workbench →
? VCR Help
✓ Approve all & submit
Edit 60
Tumor Size — unit ambiguity
Item #2800 · 82% confidence · NAACCR v24
Needs confirmation
Pathology report states "2.8 cm" while imaging states "28mm mass." Values are mathematically equivalent. NAACCR item 2800 requires millimeters — AI coded as 028. Confirm this is correct before submission.
Current value
028
= 28mm (AI coded)
Source text
"2.8 cm" — path report
"28mm" — CT imaging
✓ Confirm 028mm is correct
Edit value
Flag for senior CTR
Edit 1270
Rx Date 1st Course — date conflict
Item #1270 · 76% confidence · SEER edit
Needs confirmation
Two sources give different first treatment dates. Op note states November 5, 2024 (surgical date). Infusion log shows November 8, 2024 (first chemo). NAACCR item 1270 = earliest date of first course treatment. Surgery on Nov 5 is likely correct.
Proposed: Surgery date
20241105
Nov 5 · Op note
Alternative: Chemo date
20241108
Nov 8 · Infusion log
✓ Confirm Nov 5 (surgery)
Use Nov 8 (chemo)
Enter different date
✓ Passed Edits (448)
Show all
448/450 passing (99.6%)
Analytics
· Last 30 days
⬇ Export
AI Analytics
CLAUDE SONNET 4
De-identified data only
Ask questions in plain English — get instant insights from your registry data
🔍
Analyze →
↺ New
Try:
Stage III breast cases Q3 2024
Compare timeliness across all locations
Which cases were auto-approved by AI this month?
HER2 positive cases by site
Cases pending registry submission older than 30 days
Total cases
847
+18% vs prior period
Avg time to abstract
8.2s
11× faster than manual
AI accuracy
94.2%
+1.4% this period
VCR acceptance rate
99.5%
Best on record
Cases by Primary Site
Breast (C50.x)
72
8.5%
Colon/Rectal
48
5.7%
Lung (C34.x)
38
4.5%
Prostate (C61)
32
3.8%
Gynecologic
22
2.6%
Other
635
75%
Stage at Diagnosis
Stage I
237
28%
Stage II
263
31%
Stage III
186
22%
Stage IV
119
14%
Unknown/NA
42
5%
AI Accuracy by Field Category
Primary site / ICD-O-3
99%
Demographics
99%
Histology / Morphology
98%
Site-specific factors (ER/PR/HER2)
96%
Staging (TNM / AJCC)
94%
First course treatment
84%
Treatment dates / sequence
78%
Timeliness — 6-Month Trend
May
Jun
Jul
Aug
Sep
Oct
CoC target: 90% Current: 96.1% ↑
90%
Registry Network
US Cancer Center
National testing registry · 1 location · USR reporting
● Live · USR
Manage in Settings →
Cases YTD
847
+18% vs prior period
Pending Review
12
needs attention
AI Accuracy
94.2%
+1.4% this month
Timeliness
96.1%
of 180d · above target
Submitted YTD
100
96% accepted
USR Deadline
12d
30th of each month
Registry Location
UC
US Cancer Center
National · Testing registry
● Live
Registry
USR
NAACCR
v24
Submission
API
Deadline
30th of month
Registry Contact
USA State Registry (USR)
registry@usstatecancer.gov
Submission window: 1st–30th
EHR Connections
Epic EHR Active
Ontada G2 Active
Quest Labs Active
Submission Pathway
USR · API
Onvera → NAACCR v24 flat file → API submission → USR ✓
100
Submitted YTD
96%
Acceptance rate
4
Rejected
12
Ready to submit
AI Pipeline Status
● Live
OCR
Active
De-ID
Active
Classify
Active
Casefind
Active
Abstract
Active
Validate
Active
Avg time to abstract
8.2s 11× faster than manual
AI accuracy (avg)
94.2% +1.4% this month
Auto-routed cases
11 this session
Recent Registry Activity
Full audit log →
Walsh, C. submitted to USR — accepted
2h ago
Tanner, R. abstract approved — ready to submit
3h ago
Okonkwo, D. USR rejected — Edit 1270 date conflict
4h ago
3 path reports uploaded — queued for AI abstraction
5h ago
CoC Accreditation Readiness
94%
overall · Organization
Next survey
Mar 2026
10 months away
Standards met
31/34
3 need attention
Quality measures
4/4
all above threshold
Last accredited
2023
3-year cycle
CoC Standards Scorecard
2023 Standards
4.1
Cancer Committee
Leadership, membership, meeting frequency
✓ Met
1.3
Cancer Conference
Prospective case presentations · min 10% analytic
✓ Met
18 of 24 cases presented prospectively YTD
4.4
Timeliness of Reporting
90% of cases abstracted within 6 months of dx
✓ Met
96.1% on-time · Target: 90% · Onvera AI-driven
4.5
Follow-up of Analytic Cases
90% of living analytic cases with annual follow-up
⚠ At risk
87% current · Target: 90% · 3 patients overdue
4.6
Quality of Reported Data
Data accuracy via reabstraction audit
✓ Met
99.1% data accuracy · Last audit: Sept 2024
4.7
Cancer Registry Operations
CTR-managed registry with documented procedures
✓ Met
7.1
Psychosocial Distress Screening
Screening tool implemented for all cancer patients
✗ Gap
72% screened · Target: 100% · Action plan required
7.2
Survivorship Care Planning
Care plan provided to all completing treatment
⚠ At risk
83% receiving care plans · Target: 100%
Deficiency Tracker
2 open
Standard 7.1
Psychosocial Distress Screening gap
Due: Jan 2025
Only 72% of new cancer patients receiving distress screening. Missing NCCN-validated tool integration.
Corrective action: underway
View plan →
Standard 4.5
Follow-up rate below 90% target
Monitoring
3 patients past 12-month follow-up window. Currently at 87% — 3% below CoC minimum threshold.
Monitoring monthly
Open Follow-up →
Open Deficiencies
3 need attention
Standard 4.4 — Case completeness timeliness
2 cases beyond 6-month abstraction window · Fredericksburg (VOA-007)
Due in 14 days
Go to workbench →
Standard 7.3 — Follow-up contact rate
Follow-up rate 88% · CoC requires ≥90% · 4 patients need contact
Due this month
Go to follow-up →
Standard 1.3 — Cancer committee meeting frequency
Next scheduled meeting: November 15 · Agenda not yet submitted
Informational
Details
Cancer Conference Log · 2024
+ Add entry
Date
Cases presented
Prospective
Total
Oct 2024
Henderson, Tanner, Nguyen
3/3
3
Sep 2024
Garcia, Patel, Okonkwo, Walsh
4/4
4
Aug 2024
Kim, Lopez, Brown, Ahmed, Vasquez
5/5
5
Jul 2024
Johnson, Smith, Chen, Reyes
4/4
4
YTD total: 24 cases · Prospective: 24/24 (100%) · CoC 1.3 requires ≥10% analytic
Quality Measures · CoC 2024
All thresholds met ✓
BCSRT
Breast Conserving Surgery + Radiation Therapy
97%
threshold: 90%
34 of 35 eligible patients received RT after BCS +7% above threshold
HER2 Testing
Breast cancer patients with HER2 testing documented
100%
threshold: 90%
72 of 72 breast cancer cases with HER2 documented Perfect score
ER/PR Testing
Breast cancer with hormone receptor status documented
100%
threshold: 90%
72 of 72 breast cancer cases with ER/PR status Perfect score
nBxa12
Colon cancer with ≥12 lymph nodes examined
94%
threshold: 85%
47 of 50 resected colon cases with ≥12 nodes +9% above threshold
Upcoming Deadlines
Nov 5
REG Monthly Submission
12 cases pending · 9 days away
Submit →
Dec 31
Annual Case Completeness Audit
CoC 4.6 · Year-end reabstraction sample due
Schedule →
Jan 15
NAPBC Annual Report
Breast program data submission to NAPBC
Prepare →
Mar 26
CoC Accreditation Survey
3-year survey · 10 months away · Readiness: 94%
Readiness →
Survey Readiness Checklist
12/15 complete
✓Cancer committee meeting minutes current
✓CTR credentials on file for all registrars
✓Cancer conference logs complete (YTD)
✓Quality measures above all thresholds
✓Registry data submitted to VCR (current)
✓Timeliness ≥90% (currently 96.1%)
✓Data accuracy audit completed (99.1%)
✓Physician leadership roster current
✓Multidisciplinary team documented
✓Patient navigation program documented
✓Survivorship program plan on file
✓Palliative care referral pathway documented
⚠Psychosocial distress screening at 72% (gap)
⚠Follow-up rate at 87% — 3% below target
✗Survivorship care plan documentation gap (83%)
⬇ Export compliance report PDF
124
total in follow-up
3
overdue
11
due this month
87%
follow-up rate
🔍
+ Add contact
⚠ Overdue — past 180-day threshold
JN
James A. Nguyen
MRN-2024-09087 · Colon C18.2 · Stage III · Dx: Apr 2024
12 days overdue
Last contact: Apr 22, 2024
📞 Contact
Log contact
Next step: Phone contact attempt. If unreachable, send certified letter. Check SSDI/obituary. CoC 4.5 requires annual contact — this affects registry compliance.
LC
Leonard B. Cross
MRN-2024-09044 · Prostate C61 · Stage II · Dx: Mar 2024
8 days overdue
Last contact: Mar 18, 2024
📞 Contact
Log contact
SO
Sandra K. Oates
MRN-2024-09038 · Breast C50.4 · Stage I · Dx: Feb 2024
3 days overdue
Last contact: Feb 10, 2024
📞 Contact
Log contact
⏱ Due this month
MH
Martha L. Henderson
MRN-2024-08841 · Breast C50.4 · Stage IIA · Dx: Oct 2023
Due in 8 days
Annual follow-up · Last: Oct 3, 2023
📞 Contact
Log contact
RJ
Robert J. Tanner
MRN-2024-08839 · Colon C18.2 · Stage III · Dx: Oct 2023
Due in 15 days
Annual follow-up · Last: Oct 15, 2023
📞 Contact
Log contact
✓ On track (110 patients)
110 patients currently on track for annual follow-up. Next due dates: Nov–Dec 2024.
Audit Log
· Complete activity trail · HIPAA compliant · Tamper-evident · INTERNAL
🔍
⬇ Export
Events today
47
Submissions
12
Overrides
2
AI actions
31
Integrity
✓ Verified
Timestamp
User
Action type
Detail
Patient / MRN
Status
10:14:22
Reg
◻ submit
Batch signoff — 9 Tier 1 cases approved and submitted to VCR
Batch #NOV-2024-A
✓
10:11:08
AI
⤓ ingest
PathReport_Garcia.pdf OCR extraction completed — 34 fields extracted
Thomas R. Garcia · MRN-20…
✓
10:08:45
Reg
✓ approve
Abstract approved — T3 case sent to validation queue
Martha L. Henderson · MRN…
✓
10:06:31
AI
⤓ ingest
IHC_Report_Henderson ingested via Ontada G2 HL7 feed — classified as Lab/IHC
Martha L. Henderson · MRN…
✓
10:04:18
Reg
✎ override
Field override: Tumor Size → 028mm. Reason: Unit conflict confirmed between path…
Martha L. Henderson · MRN…
⚠
10:02:55
AI
↗ route
Case auto-routed to Workbench — Tier 3, confidence 94%, 2 flags
Martha L. Henderson · MRN…
✓
09:58:42
AI
⤓ ingest
CT_ChestAbdPelvis ingested via Epic EHR FHIR R4 — classified as Imaging
Martha L. Henderson · MRN…
✓
09:55:11
Reg
✓ approve
Casefinding confirmed reportable — C50.411, 8500/3, C50.4 trigger codes
Eleanor T. Bishop · MRN-2…
✓
09:52:08
AI
⤓ ingest
PathReport_Bishop ingested via manual upload — 98% reportability confidence
Eleanor T. Bishop · MRN-2…
✓
09:48:33
VDH
◻ submit
VCR ACK received — Batch #OCT-2024-B accepted. 98 of 100 cases accepted.
Batch #OCT-2024-B
✓
09:44:19
VDH
◻ submit
VCR NACK received — 2 cases rejected. Edit 1270 date conflict. Resubmission requ…
MRN-2024-08834, MRN-2024-…
✗
09:40:05
Reg
◻ submit
Batch submitted to VCR — 100 cases, NAACCR v24, Batch #OCT-2024-B
Batch #OCT-2024-B
✓
09:36:52
AI
✓ approve
Auto-approved 9 Tier 1 cases — confidence ≥95%, zero flags
Tanner, Patel, Walsh, Kim…
✓
09:32:41
Reg
→ login
Login — Chrome on macOS · Richmond, VA · Session started
Registrar
✓
09:28:17
AI
⤓ ingest
LabResults_Nguyen ingested via Quest Labs HL7 ORU — classified as Lab
Patricia A. Nguyen · MRN-…
✓
09:24:03
AI
↗ route
Case auto-routed to Workbench — Tier 4, confidence 63%, manual abstraction requi…
David M. Okonkwo · MRN-20…
⚠
09:20:49
AI
⤓ ingest
OpReport_Okonkwo ingested via Epic EHR — classified as EMR Note
David M. Okonkwo · MRN-20…
✓
09:16:35
Reg
✎ override
Field override: Rx Date → 20241105. Reason: Surgery date (Nov 5) confirmed as fi…
Robert J. Tanner · MRN-20…
⚠
09:12:21
AI
⤓ ingest
PathReport_Tanner ingested via Ontada G2 — 98% reportability confidence, T1 rout…
Robert J. Tanner · MRN-20…
✓
09:08:07
AI
⤓ ingest
IHC_Henderson ingested via Ontada G2 — ER+/PR+/HER2- confirmed across 2 document…
Martha L. Henderson · MRN…
✓
08:59:44
AI
⤓ ingest
3 path reports uploaded (manual batch) — queued for OCR processing
Batch upload · 3 document…
✓
08:52:18
Reg
✓ approve
Case marked non-reportable — ICD D12.6 low-grade dysplasia, behavior /0
James A. Nguyen · MRN-202…
✓
08:48:55
AI
↗ route
Case added to suspense file — elevated PSA, awaiting biopsy result
Leonard B. Cross · MRN-20…
⚠
08:44:31
AI
⤓ ingest
Automated HL7 feed received — 11 documents from Epic EHR overnight batch
Batch · 11 documents
✓
08:40:17
Reg
✓ approve
Follow-up contact logged — patient reached by phone, alive and well
Martha L. Henderson · MRN…
✓
Yesterday
VDH
◻ submit
VCR ACK — Batch #OCT-2024-A accepted. 98/100 cases. Walsh, Kim, Lopez, Brown, Ah…
Batch #OCT-2024-A
✓
Yesterday
Reg
◻ submit
Monthly batch submitted to VCR — 100 cases, October 2024
Batch #OCT-2024-A
✓
Yesterday
AI
⤓ ingest
Nightly sync completed — Quest Labs: 6 results, Epic EHR: 11 documents, Ontada: …
System sync
✓
Yesterday
Reg
✓ approve
Batch signoff — 14 Tier 1 cases approved, routed to submission queue
Batch signoff #BS-2024-10…
✓
Yesterday
AI
⤓ ingest
Cross-site duplicate alert flagged — Henderson, Martha (Houston Main vs Sugar La…
MRN-2024-08841 / MRN-SL-0…
⚠
Settings
Practices
Users & Roles
State Registry
Federal Programs
Connections
Sequence Policy
Submission Schedule
Deployment
Security & Access
+ Add Practice
Practice Hierarchy
Mother organization with child locations. Each location has its own NPI, state registry, and submission pathway.
+ Add location
+ Add organization
UC
US Cancer Center
Mother org
CoC Accredited
National · NPI 0000000001 · Testing registry
847
cases YTD
Edit org
Primary registry
USR
NAACCR version
v24
Deadline
30th of month
Submission method
API
CTR pool
1 CTR
NATIONAL — USR REPORTING
UC
US Cancer Center
National · NPI 0000000001 · FIN USCC-001
● Live
USR
Edit
+
Add a location to Organization
New VA or NC location inherits mother org CoC accreditation, shared CTR pool, and EHR connections
Users & Roles
Manage access across all VOA locations. Each user can be scoped to specific locations or given network-wide access.
+ Invite user
Network Admin
Full access — all 12 locations, settings, users, deploy
CTR / Registrar
Full workflow at assigned locations — intake, workbench, submit
Read-only
View abstracts, analytics, audit log at assigned locations
Auditor
Audit log + analytics only — no patient data at any location
User
Role
Location scope
Last active
Status
SR
Registrar
user@organization.com · CTR certified
🌐 All 12 locations
Today
Active
Edit
JM
James Mitchell
james.mitchell@voa.com · CTR certified
Richmond Main, Norfolk, Virginia Beach
3 VA locations · VCR only
Yesterday
Active
Edit
MS
Maria Santos
m.santos@voa.com · CTR certified · NC licensed
Elizabeth City NC, Kill Devil Hills NC
NC locations · NCCR + dual-report
Today
Active
Edit
PO
Dr. Patricia Osei
p.osei@voa.com · Medical Director
🌐 All 12 locations (read-only)
Apr 18
Active
Edit
CA
Compliance Auditor
audit@voa.com · External · CoC survey team
🌐 All 12 locations (audit log only)
Mar 15
Inactive
Edit
?
newregistrar@voa.com
Invited Apr 22 — has not accepted
CTR / Registrar
Chesapeake, Roanoke (pending)
—
Pending
Resend
ⓘ
Location scope restricts which cases a user can view and modify. A CTR scoped to Richmond Main cannot access Norfolk cases. Network Admins see all locations. All access is logged in the Audit Log. HIPAA minimum necessary access — Auditor role cannot view patient-level data at any location.
State Registry
Registry (VCR) — primary reporting registry for Organization.
Registry — LIVE
C-CDA · eMaRC Plus · NAACCR v24 · Monthly by 5th
Test connection
State Registry
Registry
Facility ID (FIN)
SITE-001" type="text"/>
Submission Format
C-CDA via eMaRC Plus
NAACCR Version
Monthly Deadline
5th of each month
Annual Deadline
First working day in July
Timeliness Standard
90% within 180 days of Dx
SSN Mandate
⚠ Required by Code of Virginia (9-digit full)
Registry Contact
Registry Phone
TEST Environment
PROD Environment
Save
Federal Programs
Enrollment status for federal cancer reporting programs. Most are downstream — no direct submission required.
NPCR — National Program of Cancer Registries
CDC · Mandatory · Downstream via VDH
Mandatory
172 required fields. VDH reports to CDC annually. No direct submission needed from this practice.
NAPIIA — Asian/Pacific Islander ID Algorithm
NAACCR/CDC · Downstream via VDH
Mandatory
Applied by VDH using Race 1–5 and patient name fields. Onvera collects all required fields at intake.
USCS — United States Cancer Statistics
CDC + NCI · Downstream
Mandatory
Aggregated from NPCR + SEER. Data flows: practice → VDH → NPCR → USCS. No action needed.
SEER — Surveillance Epidemiology and End Results
NCI · Virginia not a participant
N/A
Virginia is not a SEER registry. If a practice location opens in CA, CT, GA, HI, IA, KY, LA, MI, NJ, NM, UT, WA or AK — SEER activates automatically.
NCDB — National Cancer Database
American College of Surgeons · CoC required
Requires CoC
Enable CoC accreditation in Practices → Edit to activate NCDB and 19 additional required fields.
Data Source Connections
Configure EMR, lab, and imaging integrations. Onvera pulls documents automatically once connected.
● Active connections
🏥
Ontada G2
Connected · HL7 v2 · Live
· Last sync: 4 min ago · 34 docs today
↺ Sync now
Configure
34
docs today
847
total ingested
97.1%
success rate
HL7 v2
protocol
⚕️
Epic EHR — FHIR R4
Connected · FHIR R4 · Live
· Last sync: 12 min ago · 11 docs today
↺ Sync now
Configure
11
docs today
298
total ingested
98.7%
success rate
FHIR R4
protocol
🧪
Quest Diagnostics — HL7 ORU
Connected · HL7 v2 ORU · Live
· Last sync: 2 min ago · 6 results today
↺ Sync now
Configure
⏳ Setup in progress
🏨
Cerner / Oracle Health
Step 2 of 4 — Awaiting OAuth callback
Continue setup →
Cancel
✓ Credentials
→ OAuth
Test connection
Activate
Add new connection
⚕️
Epic EHR
FHIR R4 · SMART on FHIR
🏨
Cerner / Oracle
FHIR R4 · CDS Hooks
📁
SFTP Drop
Batch file delivery
🧪
LabCorp
HL7 v2 ORU · results
🖼
PACS / Imaging
DICOM · radiology reports
⚙
Custom API
REST · SOAP · HL7
Sequence Number Policy
NAACCR Item #380 — controls how Onvera AI assigns lifetime sequence numbers across all primaries.
Auto-assign confidence threshold
85%
When sequence unknown
Save
Submission Schedule
Per-location submission schedules. Virginia locations submit to VCR; North Carolina locations submit to NCCR. Schedules are independent.
Registry (VCR)
10 locations · eMaRC Plus → Virginia Web Plus → VCR/VDH · NAACCR v24
● Active
Monthly deadline
5th of month
VCR requires submission by 5th
Auto-batch day
of month
1 day buffer before deadline
Auto-submit threshold
AI confidence
Below threshold → CTR review first
Per-location overrides (optional)
Richmond Main (SITE-001)
4th · 92% · ✓ default
Secondary Campus (SITE-002)
4th · 92% · ✓ default
Norfolk (VOA-003)
4th · 92% · ✓ default
Fredericksburg (VOA-007)
3rd · 95% · custom
Edit
+ 6 more locations using default schedule
Edit all VA locations
NC Central Cancer Registry (NCCR)
2 NC locations · NCDR Web Plus → NCCR · Separate state deadline
● Active
NCCR monthly deadline
15th of month
NC deadline differs from VCR
Auto-batch day
of month
2 day buffer before NC deadline
Dual-report handling
VA residents at NC sites → both registries
Annual & Federal Submissions
NCDB (CoC Annual)
Deadline: First working day of March
Auto-submission: Feb 25 · CoC program COC-4821
VCR Annual Reconciliation
Deadline: March 31
All 10 VA locations consolidated
Architecture & Deployment
Onvera Health cloud architecture — US-East-1 (AWS) · Multi-tenant SaaS · HIPAA-eligible infrastructure · Organization deployment view
System Architecture — Organization
RESTRICTED zones CONFIDENTIAL zones INTERNAL zones
⬇ Download SVG
INTERNET / CLIENT CTR Browser Chrome / Safari · HTTPS 443 Ontada G2 HL7 v2 · Port 2575 Epic EHR · FHIR R4 SMART on FHIR · HTTPS 443 Quest Labs HL7 ORU · Port 2575 Registry / VCR eMaRC Plus · HTTPS 443 NCCR / NC DOH NCDR Web Plus · HTTPS 443 Anthropic Claude API api.anthropic.com · HTTPS 443 AWS DMZ · us-east-1 AWS WAF + Shield DDoS · OWASP rules · Rate limit Application Load Balancer HTTPS termination · ACM cert API Gateway REST + HL7 · Auth · Rate limit HL7 Listener (MLLP) Port 2575 · TLS 1.3 · ACK/NAK PRIVATE SUBNET · APP TIER · RESTRICTED Onvera App Servers ECS Fargate · 3 AZs · Auto-scale Auth Service (SSO/MFA) SAML 2.0 · SCIM 2.0 · TOTP AI Abstraction Engine Claude API proxy · De-id layer · PHI Document Processor OCR · NLP · NAACCR mapper Submission Engine NAACCR v24 · eMaRC · NCDR PRIVATE SUBNET · DATA TIER · RESTRICTED RDS PostgreSQL (Multi-AZ) AES-256 · Encrypted at rest · PHI ElastiCache (Redis) Sessions · Queue · In-transit TLS S3 Document Store SSE-KMS · Versioned · RESTRICTED CloudWatch + SIEM Audit logs · Alerts · 7yr retention AWS KMS CMK · Envelope encryption · FIPS DR / BACKUP · us-west-2 RDS Read Replica + S3 CRR RPO <1hr · RTO <4hr · Automated HTTPS 443 HL7 v2 API · TLS · De-id NAACCR v24 FIREWALL FIREWALL FIREWALL AWS CLOUD · us-east-1 · HIPAA-eligible · SOC2 Type II in progress VPC: 10.0.0.0/16 · Public subnets: 10.0.1.0/24, 10.0.2.0/24 · Private subnets: 10.0.10.0/24, 10.0.11.0/24 All data encrypted AES-256 at rest · TLS 1.3 in transit · FIPS 140-2 KMS · No data leaves US-East region SP Entity ID: https://app.onverahealth.com/saml/sp · SCIM: https://app.onverahealth.com/scim/v2 · ACS: https://app.onverahealth.com/saml/acs
Hosting
ProviderAWS us-east-1
ModelMulti-tenant SaaS
ComputeECS Fargate
DatabaseRDS PostgreSQL
StorageS3 + SSE-KMS
Availability & DR
SLA99.9% uptime
AZs3 (us-east-1a/b/c)
DR regionus-west-2
RPO< 1 hour
RTO< 4 hours
Security & Compliance
Encryption at restAES-256 / KMS
Encryption in transitTLS 1.3
HIPAA BAAAWS + Anthropic
SOC2 Type IIIn progress
PentestQ1 2025 scheduled
API Integrations & Connectivity
System
Protocol
Port
Direction
Data classification
Ontada G2
HL7 v2 MLLP
2575
Inbound
RESTRICTED PHI — path reports, lab, EMR
Epic EHR
FHIR R4 REST
443
Inbound
RESTRICTED PHI — clinical notes, imaging, demographics
Quest Diagnostics
HL7 ORU
2575
Inbound
RESTRICTED PHI — lab results, pathology
VCR / Registry
HTTPS REST
443
Outbound
RESTRICTED NAACCR v24 case records
NCCR / NC DOH
HTTPS REST
443
Outbound
RESTRICTED NAACCR v24 · NC locations only
Anthropic Claude API
HTTPS REST
443
Outbound
CONFIDENTIAL De-identified prior to API call · BAA signed
Security & Access Management
Enterprise identity management. Enterprise IAM requirements: SAML 2.0 SSO · SCIM 2.0 provisioning · MFA enforcement.
Multi-Factor Authentication (MFA)
Required for all users — must enroll before accessing PHI
● Enforced
Configure
📱
TOTP Authenticator
Google Authenticator, Authy, Microsoft Authenticator
✓ Primary method
💬
SMS / Text
One-time passcode to registered mobile number
Backup method
🔑
Hardware Key
FIDO2/WebAuthn — YubiKey or similar
Optional — high-assurance
Users enrolled
4 / 5
1 pending
Enforcement policy
Mandatory
All roles · All locations
Session timeout
8 hours
Idle: 30 min
Single Sign-On — SAML 2.0
Enterprise SSO · Connect to your organization's Identity Provider (IdP)
⏳ Not configured
Configure SSO
Onvera Entity ID (SP)
https://app.onverahealth.com/saml/sp
Assertion Consumer Service (ACS) URL
https://app.onverahealth.com/saml/acs
IdP Metadata URL
NameID Format
Attribute mapping: email → onvera_email · department → onvera_role · groups → onvera_locations
SCIM 2.0 — Automated Provisioning
Auto-provision and deprovision users when your HR or IdP system changes
⏳ Not activated
Activate
SCIM Endpoint URL
https://app.onverahealth.com/scim/v2
Bearer Token
Rotate
Provisioning actions
Data classification policy:
🔒 RESTRICTEDPHI — patient records, SSN, diagnoses CONFIDENTIALDe-identified registry data INTERNALOrg config, audit logs PUBLICAggregate statistics
Data classification:
🔒 RESTRICTED PHI — patient records, SSN, diagnoses CONFIDENTIAL De-identified registry data INTERNAL Org config, audit logs PUBLIC Aggregate statistics
Session & Access Policy
Session duration
Idle timeout
Concurrent sessions
IP allowlist
Password policy
Audit retention
SR
Registrar, CTR
Admin · Lead Registrar · Organization
● Active session
Personal Information
Edit
First name
Sarah
Last name
Reynolds
Display name
Registrar
Title
CTR — Certified Tumor Registrar
NCRA CTR Number
CTR-2019-04821
CTR Renewal
December 2026
Role & Access
Role
Admin
Practice
US Cancer Center
Access scope
DashboardIngestionWorkbenchValidationSubmissionsAnalyticsAudit LogSettingsUser Management
Contact & Verification
✉
Email address
support1@onverahealth.com
Primary · used for login and notifications
✓Verified
Change
📱
Mobile phone
(804) 555-0147
SMS alerts and two-factor authentication
✓Verified
Change
✉
Recovery email
Not set
Optional — account recovery if primary email is inaccessible
Not set
Add
Security
🔑
Password
••••••••••••
Last changed: March 3, 2025
📱
Multi-Factor Authentication (MFA)
✓ Active — Authenticator app enrolled · May 2024
Security settings →
Change password
🛡
Two-factor authentication
SMS to (804) 555-0147
Required for all Admin accounts — HIPAA compliance
✓Enabled
Manage
💻
Active sessions
1 session — Chrome on macOS
● Current · Richmond, VA · Started 8:02 AM today
Sign out all
Notification Preferences
VCR submission confirmations
Email when batch accepted or rejected by Registry
Deadline reminders
Email 7, 3, and 1 day before monthly VCR deadline
Cases needing review
Daily digest of cases flagged by Onvera AI
Follow-up overdue alerts
SMS when patient follow-up passes 6-month threshold
Login History
Date & time
Device
Location
Status
Today, 8:02 AM
Chrome · macOS
Richmond, VA
● Active
Yesterday, 7:58 AM
Chrome · macOS
Richmond, VA
Ended
Apr 23, 8:14 AM
Safari · iPhone
Richmond, VA
Ended
Apr 22, 9:01 AM
Chrome · macOS
Richmond, VA
Ended
Account Actions
Sign out of all devices
Immediately ends all active sessions on all devices
Sign out all devices
Sign out
onverahealth
Support Request
Our team responds within 4 business hours · Critical issues within 1 hour
Ticket Number
ONV-—
—
⚠
Contact Information
✕
Issue Details
0 / 2000
🟢 Low
🟡 Medium
🔴 High
🚨 Critical
Click to attach or drag & drop · Screenshots, PDFs, logs · Max 5 files · 10 MB each
support@onverahealth.com · Ticket: